forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss GLP-1s in 2025: Who's Using

Why PlexusDx Personalizes Tirzepatide Treatment to Reduce Anxiety One-size-fits-all dosing protocols ignore the genetic and neurobiological diversity that determines individual medication response

Similarly, the hypoglycemia risks with GLP-1RAs were similar among Asian T2D patients

Similarly, metabolomics has shown promise in expanding our understanding of other prevalent conditions, such as cardiovascular diseases (Shah et al., 2012), obesity (Chen et al., 2015), and type 2 diabetes (Zheng and Hu, 2015)

[DOI] [PubMed] [Google Scholar] 48.Mohammadi A, Sulaiman RA, Grossman AB

Two studies on almost 100k people associated drinking coffee (2-6 cups/day) with a reduced risk of gallbladder stones in women and of gallbladder cancer in all genders